Elevance Health Bundle

Who Owns Elevance Health?
Elevance Health, a major player in the health insurance sector, was formed through significant mergers. Its history traces back to the consolidation of WellPoint Health Networks and Anthem, Inc., eventually leading to its current identity.

Understanding the ownership of a company like Elevance Health is crucial for grasping its strategic direction and market influence. The company's journey reflects significant shifts in the healthcare landscape.
Elevance Health, a leading health insurance provider, is largely owned by institutional investors. As of December 31, 2024, the company served approximately 45.7 million medical members. In 2024, Elevance Health reported operating revenue of $175.2 billion. The company's strategic decisions and governance are heavily influenced by its shareholder base, which includes major investment firms. Analyzing the Elevance Health BCG Matrix can offer further insights into its product portfolio performance.
Who Founded Elevance Health?
The origins of Elevance Health trace back to the 1940s with the establishment of Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. in Indianapolis, Indiana. These entities were the precursors to what would eventually become Anthem, Inc. Separately, WellPoint Health Networks Inc. began with Blue Cross of California, founded in 1982.
Elevance Health's lineage includes Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc., established in Indianapolis in the 1940s. These were the foundational entities that eventually evolved into Anthem, Inc.
WellPoint Health Networks Inc.'s roots lie with Blue Cross of California, which was formed in 1982. This consolidation brought together earlier Blue Cross organizations in Northern and Southern California.
In 1992, WellPoint Health Networks was created to manage the managed care operations of Blue Cross of California. It later became a separate publicly traded company in 1993.
Blue Cross of California converted to a for-profit status in 1996. This move positioned WellPoint Health Networks Inc. as the parent organization.
Anthem, Inc. became a public company in 2001 through its initial public offering (IPO). At that time, it was the fourth largest public managed healthcare company in the U.S.
A significant merger occurred in 2004 between Anthem, Inc. and WellPoint Health Networks Inc., creating WellPoint, Inc. This entity became the largest health benefits company in the United States.
The early ownership of these foundational companies was characterized by a shift from mutual insurance structures to publicly traded entities. While specific founder equity details at the very inception are not widely publicized, initial control often resided with the original non-profit organizations or was established through the process of initial public offerings. This historical trajectory laid the groundwork for the current ownership structure of Elevance Health, a publicly traded company with a broad shareholder base.
The evolution of Elevance Health's ownership involved several critical stages, from its mutual insurance company beginnings to its current status as a major publicly traded healthcare provider. Understanding these historical shifts is key to grasping the company's overall ownership structure.
- Establishment of Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. in the 1940s.
- Founding of Blue Cross of California in 1982.
- Formation of WellPoint Health Networks in 1992 and its subsequent IPO in 1993.
- Blue Cross of California's conversion to for-profit status in 1996.
- Anthem, Inc.'s IPO in 2001.
- The 2004 merger creating WellPoint, Inc.
- The company's rebranding to Elevance Health in 2022.
Elevance Health SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format

How Has Elevance Health’s Ownership Changed Over Time?
Elevance Health's journey as a publicly traded entity began with its demutualization and Initial Public Offering in 2001. The subsequent merger with WellPoint Health Networks in 2004 significantly reshaped its corporate structure and ownership landscape.
Major Institutional Shareholder | Shares Held (as of March 31, 2025) | Ownership Percentage (approximate) |
---|---|---|
Vanguard Group Inc. | 22,152,108 | ~9.75% |
BlackRock, Inc. | 21,311,015 | ~9.37% |
State Street Corp. | 10,647,703 | ~4.68% |
Price T Rowe Associates Inc /Md/ | 9,142,563 | ~4.02% |
Wellington Management Group Llp | 5,794,794 | ~2.55% |
Capital International Investors | 5,555,887 | ~2.44% |
The ownership structure of Elevance Health is heavily dominated by institutional investors, reflecting its status as a major publicly traded company on the NYSE under the ticker ELV. As of March 31, 2025, these large investment entities collectively held approximately 89.24% of the company's stock. This significant institutional backing, comprising major asset managers, mutual funds, and index funds, suggests a focus on long-term growth and stable corporate governance. The company's history, including its IPO in 2001 and the 2004 merger that led to the formation of WellPoint, Inc. (later rebranded), has established a broad shareholder base. By December 31, 2024, Elevance Health had a total of approximately 227,351,871 shares of common stock outstanding, with the majority held by these institutional stakeholders.
Elevance Health's ownership is primarily concentrated among large institutional investors, indicating a stable and professionally managed shareholder base.
- Elevance Health is a publicly traded company on the NYSE (ELV).
- Institutional investors held about 89.24% of the company's stock as of March 31, 2025.
- Key institutional shareholders include Vanguard Group Inc. and BlackRock, Inc.
- The company's ownership structure evolved significantly after its 2001 IPO and the 2004 merger with WellPoint Health Networks.
- This broad institutional ownership influences strategic and governance decisions, aligning with long-term value creation.
Elevance Health PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable

Who Sits on Elevance Health’s Board?
The current Board of Directors at Elevance Health is instrumental in guiding the company's strategic direction and governance. As detailed in the 2024 Proxy Statement, the board comprises a mix of seasoned executives and independent directors, including President and CEO Gail Koziara Boudreaux and Independent Chair Elizabeth E. Tallett.
Director Name | Position | Key Role |
---|---|---|
Gail Koziara Boudreaux | President and CEO | Executive Leadership |
Elizabeth E. Tallett | Independent Chair of the Board | Board Governance Oversight |
Steve Collis | Director (Appointed August 1, 2025) | Enhanced Healthcare Expertise |
Elevance Health adheres to a one-share-one-vote principle for its common stock, ensuring each share carries equal voting power. Importantly, as of February 1, 2025, neither individual directors nor executive officers, nor the group as a whole, beneficially owned more than 1% of the company's outstanding common stock. This structure underscores a broad distribution of ownership rather than concentrated control by insiders.
Elevance Health's corporate governance framework is designed to empower shareholders. The company employs a majority voting standard for director elections in uncontested scenarios and offers proxy access for shareholder-nominated director candidates.
- One-share-one-vote structure for common stock.
- No cumulative voting rights for shareholders.
- Shareholders possess the right to call special meetings.
- Three director nominees received strong shareholder support in May 2025 elections.
- Steve Collis joined the board in August 2025, bolstering industry expertise.
Understanding the ownership structure is key to grasping the dynamics of Elevance Health. The company's commitment to good governance is reflected in its board composition and voting rights policies, which aim to align the interests of management with those of its diverse shareholder base. For a deeper dive into the company's market positioning, exploring the Target Market of Elevance Health provides valuable context.
Elevance Health Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout

What Recent Changes Have Shaped Elevance Health’s Ownership Landscape?
Over the past few years, Elevance Health has maintained a strong institutional ownership base, with minor shifts observed in early 2025. While institutional holdings saw a slight decrease, insider ownership experienced a marginal increase, reflecting continued confidence from company leadership.
Investor Type | March 2025 Holding (%) | Previous Holding (%) |
---|---|---|
Institutional Investors | 91.92 | 92.38 |
Mutual Funds | 91.29 | 91.35 |
Insider Holdings | 0.15 | 0.14 |
Elevance Health has been strategically expanding its reach and capabilities through significant acquisitions and partnerships. The company is actively growing its market presence in states like Florida, Maryland, and Texas, utilizing its Simply Healthcare and Wellpoint brands. A notable development in primary care delivery involves a strategic partnership with Clayton, Dubilier & Rice, integrating Elevance Health's care delivery assets with apree health and Millennium Physician Group to serve nearly one million consumers. This initiative is designed to be accessible to all payers. The company also continued its commitment to shareholder value through share repurchases, buying back 4.5 million shares for $1.8 billion in Q4 2024, with substantial remaining authorization. These moves underscore a strategy focused on both market expansion and efficient capital allocation, as detailed in the Revenue Streams & Business Model of Elevance Health article.
Elevance Health is actively entering new markets in Florida, Maryland, and Texas in 2025. These expansions utilize the company's Simply Healthcare and Wellpoint brands to broaden its service footprint.
A partnership with Clayton, Dubilier & Rice aims to advance primary care delivery. This collaboration involves integrating care delivery assets to serve a significant consumer base.
The company repurchased 4.5 million shares for $1.8 billion in late 2024. A substantial $9.3 billion in share repurchase authorization remained as of December 31, 2024.
An agreement to acquire Blue Cross and Blue Shield of Louisiana was announced in 2023. This acquisition is projected to add 1.9 million members and expand the company's reach to 15 states.
Elevance Health Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked

- What is Brief History of Elevance Health Company?
- What is Competitive Landscape of Elevance Health Company?
- What is Growth Strategy and Future Prospects of Elevance Health Company?
- How Does Elevance Health Company Work?
- What is Sales and Marketing Strategy of Elevance Health Company?
- What are Mission Vision & Core Values of Elevance Health Company?
- What is Customer Demographics and Target Market of Elevance Health Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.